» Articles » PMID: 36394512

Connecting Epicardial Adipose Tissue and Heart Failure with Preserved Ejection Fraction: Mechanisms, Management and Modern Perspectives

Overview
Publisher Wiley
Date 2022 Nov 17
PMID 36394512
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is very common in patients with heart failure with preserved ejection fraction (HFpEF) and it has been suggested that obesity plays an important role in the pathophysiology of this disease. While body mass index defines the presence of obesity, this measure provides limited information on visceral adiposity, which is probably more relevant in the pathophysiology of HFpEF. Epicardial adipose tissue is the visceral fat situated directly adjacent to the heart and recent data demonstrate that accumulation of epicardial adipose tissue is associated with the onset, symptomatology and outcome of HFpEF. However, the mechanisms by which epicardial adipose tissue may be involved in HFpEF remain unclear. It is also questioned whether epicardial adipose tissue may be a specific target for therapy for this disease. In the present review, we describe the physiology of epicardial adipose tissue and the pathophysiological transformation of epicardial adipose tissue in response to chronic inflammatory diseases, and we postulate conceptual mechanisms on how epicardial adipose tissue may be involved in HFpEF pathophysiology. Lastly, we outline potential treatment strategies, knowledge gaps and directions for further research.

Citing Articles

Epicardial adipose tissue: a new link between type 2 diabetes and heart failure-a comprehensive review.

Zhang S, Wang S, Liu S, Li P, Huang D, Zeng X Heart Fail Rev. 2024; .

PMID: 39730926 DOI: 10.1007/s10741-024-10478-8.


Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy.

Xu Y, Guo J, Li Y, Wang S, Wan K, Li W Cardiovasc Diabetol. 2024; 23(1):447.

PMID: 39696268 PMC: 11657914. DOI: 10.1186/s12933-024-02517-3.


Chest-CT-based radiomics feature of epicardial adipose tissue for screening coronary atherosclerosis.

Wei Q, Chen Y, Yuan D, Nie F, Li J, Yu K Heart Vessels. 2024; .

PMID: 39540983 DOI: 10.1007/s00380-024-02479-2.


Epicardial adipose tissue and exercise intolerance in HFpEF.

Lobeek M, Gorter T, Rienstra M Int J Cardiol Heart Vasc. 2024; 54:101485.

PMID: 39415966 PMC: 11481610. DOI: 10.1016/j.ijcha.2024.101485.


Characteristics of gene expression in epicardial adipose tissue and subcutaneous adipose tissue in patients at risk for heart failure undergoing coronary artery bypass grafting.

Frisk C, Ekstrom M, Eriksson M, Corbascio M, Hage C, Persson H BMC Genomics. 2024; 25(1):938.

PMID: 39375631 PMC: 11457432. DOI: 10.1186/s12864-024-10851-9.


References
1.
Smail H, Baciu A, Dacher J, Litzler P . Surgical resection of circumferential epicardial adipose tissue hypertrophy: Case report and systematic review of the literature. J Thorac Cardiovasc Surg. 2015; 151(2):e27-30. DOI: 10.1016/j.jtcvs.2015.08.083. View

2.
Suthahar N, Meems L, Withaar C, Gorter T, Kieneker L, Gansevoort R . Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Sci Rep. 2022; 12(1):147. PMC: 8741934. DOI: 10.1038/s41598-021-02409-6. View

3.
Yudkin J, Eringa E, Stehouwer C . "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005; 365(9473):1817-20. DOI: 10.1016/S0140-6736(05)66585-3. View

4.
van Woerden G, Gorter T, Westenbrink B, Willems T, Van Veldhuisen D, Rienstra M . Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. Eur J Heart Fail. 2018; 20(11):1559-1566. PMC: 6607508. DOI: 10.1002/ejhf.1283. View

5.
Kim S, Kim M, Shim W, Park S . Epicardial adipose tissue is related to cardiac function in elderly women, but not in men. Nutr Metab Cardiovasc Dis. 2016; 27(1):41-47. DOI: 10.1016/j.numecd.2016.11.001. View